Research focus
About the research
What drives the pathophysiology of Alzheimer disease and Parkinson disease?
Read the full research overview
Benjamin Wolozin joined the Boston University School of Medicine Department of Pharmacology in 2004 as a Professor. His work on Alzheimer disease examines the role of cholesterol in the pathophysiology of the disease. His work on Parkinson disease examines the interaction between genes implicated in the disease and environmental factors implicated in the disease. He studies neurodegenerative disease using molecular biology, cellular biology, transgenic mice, study of human brain samples and epidemiological database analyses.
Selected publications
3 listedInteraction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
Molecular Cell
TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau
Proceedings of the National Academy of Sciences
GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease-like filaments
Proceedings of the National Academy of Sciences
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings